• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

5 More Top Endo Apps for Primary Care

News
Slideshow

Apps to guide osteoporosis treatment, insulin management, endocrine emergencies, plus ADA and Endo Society standards of care, at-a-glance.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose / Image credit: ©New Africa/AdobeStock

Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose

Sydney Jennings
September 30th 2025
Article

Your daily dose of the clinical news you may have missed.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Tirzepatide Lowers A1C and BMI in Children and Adolescents with Type 2 Diabetes /image credit Riley Children's Health

Tirzepatide Lowers A1C and BMI in Children and Adolescents with Type 2 Diabetes

Grace Halsey
September 18th 2025
Article

In children aged 10 to <18 with T2D inadequately controlled on standard of care treatment, tirzepatide reduced HbA1c by an average of 2.2% and reduced BMI as well.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

FDA Approves Automated Insulin Delivery System for Adults With T2D: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Automated Insulin Delivery System for Adults With T2D: Daily Dose

Sydney Jennings
September 16th 2025
Article

Your daily dose of the clinical news you may have missed.

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

Grace Halsey
September 10th 2025
Article

Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.

© 2025 MJH Life Sciences

All rights reserved.